glp-1 and prostate cancer

glp-1 and prostate cancer Targeting obesity, metabolic syndrome, cancer: agonists as emerging therapeutic agents | Discover Oncology Glucagon‐like peptide‐1 receptor (GLP‐1R) expression

Name: glp-1 and prostate cancer Targeting obesity, metabolic syndrome, cancer: agonists as emerging therapeutic agents | Discover Oncology Glucagon‐like peptide‐1 receptor (GLP‐1R) expression
Brand: woovina.de
SKU: 16543620172
Price: 21.13 USD
Availability: InStock
Rating: 4.6858 (29 reviews)

SKU: 16543620172

4.7

EUR21.13 EUR54.13

Pay in 4 interest-free payments of $5.28 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

Description

PubMed Central, Kummer, Wolfgang, and Klaus Deckmann

Brice NL, Schiffer HH, Monenschein H, Mulligan VJ, Page K, Powell J, et al

Ocaliva, a farsenoid X receptor agonist, won the FDAs accelerated approval for PBC in May 2016

However, the journey from promising animal data to effective human therapies is fraught with substantial challenges that must be balanced against the initial optimism